Ross John Solaro

Q: What Schools Are Affiliated With Ross John Solaro

Ross John Solaro is affiliated with the following schools: Texas A&M University, Rush University, University of Manchester, King's College London, University of Illinois Chicago, University of Maryland, College Park, University of Coimbra, University of Cincinnati, University of Alberta

Ross John Solaro's AcademicInfluence.com Rankings

Ross John Solaro

Biology

#10694

World Rank

#14046

Historical Rank

Cell Biology

#515

World Rank

#527

Historical Rank

Molecular Biology

#1580

World Rank

#1608

Historical Rank

Neuroscience

#1675

World Rank

#1727

Historical Rank

biology Degrees

Download Badge

Biology

Ross John Solaro's Degrees

PhD Biochemistry University of California, Berkeley
Masters Molecular Biology Stanford University

Why Is Ross John Solaro Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ross John Solaro's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Protein Kinase C ζ (2007) (408)
Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. (1998) (369)
Regulation of cardiac contractile function by troponin I phosphorylation. (2005) (352)
Phosphorylation of Troponin I by Protein Kinase A Accelerates Relaxation and Crossbridge Cycle Kinetics in Mouse Ventricular Muscle (2001) (336)
Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. (2008) (253)
Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. (1998) (246)
Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart (1999) (220)
Biology of the troponin complex in cardiac myocytes. (2004) (187)
Calcium-induced structural transition in the regulatory domain of human cardiac troponin C. (1997) (186)
Mechanisms and Use of Calcium-Sensitizing Agents in the Failing Heart (2006) (182)
Augmented Protein Kinase C-α–Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure (2007) (171)
Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. (1993) (170)
S-Glutathionylation of Cryptic Cysteines Enhances Titin Elasticity by Blocking Protein Folding (2014) (165)
Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium Sensitivity (2010) (162)
Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. (1999) (162)
Effects of diacetyl monoxime on cardiac excitation-contraction coupling. (1985) (156)
Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers. (1987) (154)
Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. (2003) (142)
Altered interactions among thin filament proteins modulate cardiac function. (1996) (140)
Modification of calcium requirement for activation of cardiac myofibrillar ATPase by cyclic AMP dependent phosphorylation (1979) (135)
A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. (2001) (133)
The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. (2008) (131)
A Novel Cardiomyocyte-enriched MicroRNA, miR-378, Targets Insulin-like Growth Factor 1 Receptor (2012) (131)
Phospholamban gene dosage effects in the mammalian heart. (1996) (125)
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. (2010) (123)
Intracellular Localization and Functional Effects of P21-Activated Kinase-1 (Pak1) in Cardiac Myocytes (2004) (116)
Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. (2001) (115)
The Troponin C G159D Mutation Blunts Myofilament Desensitization Induced by Troponin I Ser23/24 Phosphorylation (2007) (114)
Ablation of Ventricular Myosin Regulatory Light Chain Phosphorylation in Mice Causes Cardiac Dysfunction in Situ and Affects Neighboring Myofilament Protein Phosphorylation* (2009) (113)
Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. (2007) (110)
Changes in myofibrillar activation and troponin C Ca2+ binding associated with troponin T isoform switching in developing rabbit heart. (1990) (110)
Multiplex Kinase Signaling Modifies Cardiac Function at the Level of Sarcomeric Proteins* (2008) (110)
Integration of troponin I phosphorylation with cardiac regulatory networks. (2013) (108)
Molecular and Physiological Effects of α-Tropomyosin Ablation in the Mouse (1998) (107)
Protein Phosphorylation and Signal Transduction in Cardiac Thin Filaments* (2011) (107)
The C Terminus of Cardiac Troponin I Is Essential for Full Inhibitory Activity and Ca2+ Sensitivity of Rat Myofibrils* (1997) (101)
Dilated Cardiomyopathy Mutant Tropomyosin Mice Develop Cardiac Dysfunction With Significantly Decreased Fractional Shortening and Myofilament Calcium Sensitivity (2007) (101)
The contractile apparatus as a target for drugs against heart failure: Interaction of levosimendan, a calcium sensitiser, with cardiac troponin c (2004) (100)
The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. (1995) (100)
PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation (2010) (100)
p38-MAPK Induced Dephosphorylation of &agr;-Tropomyosin Is Associated With Depression of Myocardial Sarcomeric Tension and ATPase Activity (2007) (100)
Conformation of the Regulatory Domain of Cardiac Muscle Troponin C in Its Complex with Cardiac Troponin I* (1999) (98)
Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart (2011) (93)
Ca2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T (2001) (92)
Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin. (2007) (92)
Exchange of - for -Tropomyosin in Hearts of Transgenic Mice Induces Changes in Thin Filament Response to Ca, Strong Cross-bridge Binding, and Protein Phosphorylation (*) (1996) (92)
The significance of regulatory light chain phosphorylation in cardiac physiology. (2011) (91)
Protection against endotoxemia‐induced contractile dysfunction in mice with cardiac‐specific expression of slow skeletal troponin I (2005) (91)
Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C. (1997) (91)
FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling. (2010) (89)
Cardiac troponin T isoforms affect the Ca(2+) sensitivity of force development in the presence of slow skeletal troponin I: insights into the role of troponin T isoforms in the fetal heart. (2004) (88)
NMR analysis of cardiac troponin C‐troponin I complexes: effects of phosphorylation (1999) (87)
Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. (1996) (86)
Correlation between myofilament response to Ca2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express beta-tropomyosin. (1999) (86)
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury (2011) (86)
A Cardiac-enriched MicroRNA, miR-378, Blocks Cardiac Hypertrophy by Targeting Ras Signaling* (2013) (85)
Molecular and Functional Characterization of a Novel Cardiac-Specific Human Tropomyosin Isoform (2009) (83)
Protein Kinase C&egr; Overexpression Alters Myofilament Properties and Composition During the Progression of Heart Failure (2004) (83)
Differential effects of pH on calcium activation of myofilaments of adult and perinatal dog hearts. Evidence for developmental differences in thin filament regulation. (1986) (83)
A dominant role of cardiac molecular motors in the intrinsic regulation of ventricular ejection and relaxation. (2007) (80)
Mutagenesis of cardiac troponin I. Role of the unique NH2-terminal peptide in myofilament activation. (1994) (78)
Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I (2000) (77)
Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions (2001) (76)
Vanadate and phosphate ions reduce tension and increase cross-bridge kinetics in chemically skinned heart muscle. (1981) (75)
Systems Approach to Understanding Electromechanical Activity in the Human Heart: A National Heart, Lung, and Blood Institute Workshop Summary (2008) (75)
Phosphorylation-induced distance change in a cardiac muscle troponin I mutant. (1997) (74)
Identification and functional significance of troponin I isoforms in neonatal rat heart myofibrils. (1991) (74)
The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments. (1999) (73)
Why does troponin I have so many phosphorylation sites? Fact and fancy. (2010) (72)
Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties. (2013) (72)
The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium. (2013) (70)
Structure of the C-domain of Human Cardiac Troponin C in Complex with the Ca2+ Sensitizing Drug EMD 57033* (2001) (69)
Tyrosine Phosphorylation Modifies Protein Kinase C δ-dependent Phosphorylation of Cardiac Troponin I* (2008) (69)
NMR studies delineating spatial relationships within the cardiac troponin I-troponin C complex. (1994) (68)
Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. (2006) (66)
Troponin I serines 43/45 and regulation of cardiac myofilament function. (2002) (64)
Long-Term Biased &bgr;-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy (2017) (63)
Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation. (2006) (62)
Desensitization of Myofilaments to Ca2+ as a Therapeutic Target for Hypertrophic Cardiomyopathy With Mutations in Thin Filament Proteins (2014) (62)
An Essential Myosin Light Chain Peptide Induces Supramaximal Stimulation of Cardiac Myofibrillar ATPase Activity* (1996) (61)
Effects of Troponin I Phosphorylation on Conformational Exchange in the Regulatory Domain of Cardiac Troponin C* (1999) (60)
Integration of Cardiac Myofilament Activity and Regulation with Pathways Signaling Hypertrophy and Failure (2000) (60)
A Novel, In-solution Separation of Endogenous Cardiac Sarcomeric Proteins and Identification of Distinct Charged Variants of Regulatory Light Chain* (2010) (58)
N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy. (2015) (58)
Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics. (2010) (58)
Expression of Slow Skeletal Troponin I in Hearts of Phospholamban Knockout Mice Alters the Relaxant Effect of &bgr;-Adrenergic Stimulation (2002) (58)
Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. (2001) (58)
Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. (2011) (56)
Effect of thyroid status on thin-filament Ca2+ regulation and expression of troponin I in perinatal and adult rat hearts. (1990) (56)
Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. (2001) (54)
Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites. (2001) (53)
Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. (2007) (53)
NMR studies of Ca2+ binding to the regulatory domains of cardiac and E41A skeletal muscle troponin C reveal the importance of site I to energetics of the induced structural changes. (1997) (52)
Use of 2‐D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy (2008) (52)
Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation. (2002) (52)
Regulation of L-Type Calcium Channel and Delayed Rectifier Potassium Channel Activity by p21-Activated Kinase-1 in Guinea Pig Sinoatrial Node Pacemaker Cells (2007) (52)
Isoform specific interactions of troponin I and troponin C determine pH sensitivity of myofibrillar Ca2+ activation. (1994) (51)
Regulation of cardiac excitation and contraction by p21 activated kinase-1. (2008) (51)
A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin (2013) (51)
Solution structures of the C-terminal domain of cardiac troponin C free and bound to the N-terminal domain of cardiac troponin I. (1999) (50)
Mechanisms of the Frank-Starling law of the heart: the beat goes on. (2007) (50)
Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C (2013) (49)
Sexual dimorphism in rat left atrial function and response to adrenergic stimulation (1999) (49)
Cardiac troponin I induced conformational changes in cardiac troponin C as monitored by NMR using site-directed spin and isotope labeling. (1995) (48)
Sarcomere Control Mechanisms and the Dynamics of the Cardiac Cycle (2010) (48)
Regulatory Domain Conformational Exchange and Linker Region Flexibility in Cardiac Troponin C Bound to Cardiac Troponin I* (2000) (47)
Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy. (2010) (47)
Protein phosphorylation in heart muscle (1986) (47)
Control of myofilament activation in heart failure (1993) (46)
Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo. (2004) (46)
Expression of Slow Skeletal Troponin I in Adult Mouse Heart Helps to Maintain the Left Ventricular Systolic Function During Respiratory Hypercapnia (2005) (45)
β-Arrestin mediates the Frank–Starling mechanism of cardiac contractility (2016) (44)
Conformation of the N-terminal segment of a monocysteine mutant of troponin I from cardiac muscle. (1997) (43)
p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility. (2007) (43)
Troponin I isoforms and differential effects of acidic pH on soleus and cardiac myofilaments. (1995) (43)
Computational studies of the effect of the S23D/S24D troponin I mutation on cardiac troponin structural dynamics. (2014) (42)
Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes. (2009) (41)
Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K (2015) (41)
Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. (1998) (41)
A novel and personalized rehabilitation program for obese kidney transplant recipients. (2014) (40)
Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy. (2000) (39)
Functional Importance of the Carboxyl-terminal Region of Striated Muscle Tropomyosin* (2003) (39)
Western Diet-Fed, Aortic-Banded Ossabaw Swine (2019) (38)
Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction. (2005) (38)
An improved method for exchanging troponin subunits in detergent skinned rat cardiac fiber bundles. (1999) (38)
CapZ dynamics are altered by endothelin-1 and phenylephrine via PIP2- and PKC-dependent mechanisms. (2009) (38)
Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis. (2007) (37)
Interventricular differences in myofilament function in experimental congestive heart failure (2011) (37)
Review focus series: sarcomeric proteins as key elements in integrated control of cardiac function. (2007) (36)
Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH. (2001) (36)
Tropomyosin Ser-283 pseudo-phosphorylation slows myofibril relaxation. (2013) (36)
Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43. (2011) (35)
Differential regulation of slow-skeletal and cardiac troponin I mRNA during development and by thyroid hormone in rat heart. (1994) (35)
Molecular Control Mechanisms in Striated Muscle Contraction (2002) (34)
Heavy long-term ethanol consumption induces an alpha- to beta-myosin heavy chain isoform transition in rat (1999) (34)
Myosin light chain phosphatase: a Cinderella of cellular signaling. (2000) (33)
Ca2+, pH and the regulation of cardiac myofilament force and ATPase activity (1989) (33)
Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β (TGFβ1)-dependent paracrine mechanism. (2017) (33)
Deficiency of Cardiomyocyte-specific MicroRNA-378 Contributes to the Development of Cardiac Fibrosis Involving a Transforming Growth Factor β (TGFβ1)-dependent Paracrine Mechanism* (2014) (33)
H2O2 alters rat cardiac sarcomere function and protein phosphorylation through redox signaling. (2010) (33)
Cardiac relaxation and myofibrillar interactions with phosphate and vanadate. (1980) (31)
Maintenance of adult cardiac function requires the chromatin factor Asxl2. (2012) (30)
Interactions at the NH2-terminal interface of cardiac troponin I modulate myofilament activation. (1999) (30)
Molecular mechanisms regulating the myofilament response to Ca2+: Implications of mutations causal for familial hypertrophic cardiomyopathy (2004) (29)
Inhibition of Angiotensin II-Induced Cardiac Hypertrophy and Associated Ventricular Arrhythmias by a p21 Activated Kinase 1 Bioactive Peptide (2014) (29)
Decreasing Tropomyosin Phosphorylation Rescues Tropomyosin-induced Familial Hypertrophic Cardiomyopathy* (2013) (29)
Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model. (2015) (29)
A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation. (2016) (29)
Modulation of Cardiac Myofilament Activity by Protein Phosphorylation (2011) (28)
Thyroid Hormone Receptor α1 Regulates Expression of the Na+/H+ Exchanger (NHE1)* (2002) (27)
Myosin and why hearts fail. (1992) (27)
Integration of pathways that signal cardiac growth with modulation of myofilament activity (2002) (27)
Identification of a Region of Troponin I Important in Signaling Cross-bridge-dependent Activation of Cardiac Myofilaments* (2007) (27)
p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes. (2014) (27)
Pak1 Is Required to Maintain Ventricular Ca 2+ Homeostasis and Electrophysiological Stability Through SERCA2a Regulation in Mice (2014) (27)
Differential expression of TnI and TnT isoforms in rabbit heart during the perinatal period and during cardiovascular stress. (1995) (27)
Regulation of Ca2+ transient by PP2A in normal and failing heart (2015) (26)
Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation (2011) (26)
Molecular actions of drugs that sensitize cardiac myofilaments to Ca 2+ (2002) (26)
Ca2+ activation and tension cost in myofilaments from mouse hearts ectopically expressing enteric γ-actin (2002) (25)
In situ time-resolved FRET reveals effects of sarcomere length on cardiac thin-filament activation. (2014) (25)
p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation. (2012) (25)
Tropomyosin Dephosphorylation Results in Compensated Cardiac Hypertrophy* (2012) (24)
Ceramide-mediated depression in cardiomyocyte contractility through PKC activation and modulation of myofilament protein phosphorylation (2014) (23)
Cardiac myofilament protein function is altered during sepsis. (1998) (23)
Striated muscle tropomyosin isoforms differentially regulate cardiac performance and myofilament calcium sensitivity (2010) (22)
Conserved Asp-137 Is Important for both Structure and Regulatory Functions of Cardiac α-Tropomyosin (α-TM) in a Novel Transgenic Mouse Model Expressing α-TM-D137L* (2013) (22)
Protein kinase C depresses cardiac myocyte power output and attenuates myofilament responses induced by protein kinase A (2012) (22)
Sites of Intra- and Intermolecular Cross-linking of the N-terminal Extension of Troponin I in Human Cardiac Whole Troponin Complex* (2009) (22)
Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy–Associated Mutation in Human Cardiac Troponin I (K206I) (2015) (21)
PAK1 is a novel cardiac protective signaling molecule (2014) (21)
Structural basis for the in situ Ca(2+) sensitization of cardiac troponin C by positive feedback from force-generating myosin cross-bridges. (2013) (21)
Metabolic Efficiency Promotes Protection From Pressure Overload in Hearts Expressing Slow Skeletal Troponin I (2015) (21)
Integration of myofilament response to Ca2+ with cardiac pump regulation and pump dynamics. (1999) (21)
Post-translational modifications of myofilament proteins involved in length-dependent prolongation of relaxation in rabbit right ventricular myocardium. (2012) (20)
Functional defects in troponin and the systems biology of heart failure. (2002) (20)
Molecular mechanisms of cardiac myofilament activation: modulation by pH and a troponin T mutant R92Q (2002) (20)
Maladaptive modifications in myofilament proteins and triggers in the progression to heart failure and sudden death (2014) (20)
Genetics of dilated cardiomyopathy: more genes that kill. (2004) (19)
Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia. (2011) (18)
Regulation of Cardiac Contractility (2010) (18)
Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling. (2010) (18)
Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy. (2003) (18)
Maintaining cooperation among cardiac myofilament proteins through thick and thin (2009) (17)
Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders (2020) (17)
Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase (2010) (17)
Remote control of A-band cardiac thin filaments by the I-Z-I protein network of cardiac sarcomeres. (2005) (17)
Modulation of Thin Filament Activity in Long and Short Term Regulation of Cardiac Function (2002) (16)
Functional integrity of the T-tubular system in cardiomyocytes depends on p21-activated kinase 1. (2013) (16)
Control and Modulation of Contractile Activity of Cardiac Myofilaments (1989) (16)
The curious role of sarcomeric proteins in control of diverse processes in cardiac myocytes (2010) (16)
CK-1827452, a sarcomere-directed cardiac myosin activator for acute and chronic heart disease. (2009) (16)
New insights into the functional significance of the acidic region of the unique N-terminal extension of cardiac troponin I. (2013) (15)
Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy. (2019) (15)
Loss of p21-activated kinase 1 (Pak1) promotes atrial arrhythmic activity. (2018) (15)
Correlations between alterations in length-dependent Ca2+ activation of cardiac myofilaments and the end-systolic pressure–volume relation (2008) (15)
Heart failure, ischemia/reperfusion injury and cardiac troponin. (2007) (15)
Physiological significance of troponin T binding domains in striated muscle tropomyosin. (2004) (15)
Myofilament proteins: From cardiac disorders to proteomic changes (2008) (15)
Novel roles of PAK1 in the heart (2012) (15)
Novel insights into sarcomere regulatory systems control of cardiac thin filament activation (2021) (15)
Functional effects of a tropomyosin mutation linked to FHC contribute to maladaptation during acidosis. (2011) (14)
Early sensitization of myofilaments to Ca2+ prevents genetically linked dilated cardiomyopathy in mice (2017) (14)
Phosphate and vanadate reduce the efficiency of the chemo-mechanical energy transformation in cardiac muscle. (1982) (14)
Cardiac Myosin Binding Protein-C Phosphorylation Mitigates Age-Related Cardiac Dysfunction (2019) (14)
Knockout of p21-activated kinase-1 attenuates exercise-induced cardiac remodelling through altered calcineurin signalling. (2015) (14)
PR65A Phosphorylation Regulates PP2A Complex Signaling (2014) (13)
JNK2, A Newly-Identified SERCA2 Enhancer, Augments an Arrhythmic [Ca2+]SR Leak-Load Relationship. (2020) (13)
Sarcomere length–dependent effects on Ca2+-troponin regulation in myocardium expressing compliant titin (2018) (13)
FTY 720 prevents ischemia / reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak 1 / Akt signaling (2011) (13)
An internal domain of beta-tropomyosin increases myofilament Ca(2+) sensitivity. (2009) (12)
Tropomyosin pseudo-phosphorylation results in dilated cardiomyopathy (2018) (12)
Differential effects of phosphorylation of regions of troponin I in modifying cooperative activation of cardiac thin filaments. (2009) (12)
Ca(2+) activation and tension cost in myofilaments from mouse hearts ectopically expressing enteric gamma-actin. (2002) (12)
Sarcomere length dependent effects on the interaction between cTnC and cTnI in skinned papillary muscle strips. (2016) (11)
Inhibition of endothelial barrier dysfunction by P21-activated kinase-1. (2007) (11)
Troponin C - troponin I interactions and molecular signalling in cardiac myofilaments. (1995) (11)
The special structure and function of troponin I in regulation of cardiac contraction and relaxation. (2003) (11)
Novel insights into mechanisms for Pak1-mediated regulation of cardiac Ca2+ homeostasis (2015) (11)
Cardiomyocyte-specific expression of CRNK, the C-terminal domain of PYK2, maintains ventricular function and slows ventricular remodeling in a mouse model of dilated cardiomyopathy. (2014) (11)
Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signaling (2013) (10)
Development and Cardiac Contractility: Cardiac Troponin T Isoforms and Cytosolic Calcium in Rabbit (2006) (10)
Peroxisome proliferator-activated receptor-α expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy. (2017) (9)
Is calcium the 'cure' for dilated cardiomyopathy? (1999) (9)
Why is it important to analyze the cardiac sarcomere subproteome? (2010) (9)
Use of a decoy peptide to purify p21 activated kinase-1 in cardiac muscle and identification of ceramide-related activation (2008) (9)
Modifications of Sarcoplasmic Reticulum Function Prevent Progression of Sarcomere-Linked Hypertrophic Cardiomyopathy Despite a Persistent Increase in Myofilament Calcium Response (2020) (9)
Abstract of free communicationsIntracellular actions of APP 201–533, a novel cardiotonic agent: Increase in Ca++sensitivity and economization of the myocardial contractile process (1983) (9)
Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes. (2014) (8)
Intracellular Localization and Functional Effects of P 21-Activated Kinase-1 ( Pak 1 ) in Cardiac Myocytes (2003) (8)
Depressed myofilament co-operativity associated with post-cardioplegic myocardial depression. (1998) (7)
Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N (2021) (7)
Coordination of metabolism and contractility by phosphorylation in cardiac, skeletal, and smooth muscle. Introduction. (1983) (7)
CHAPTER 30 – Mechanisms Regulating Cardiac Myofilament Response to Calcium (2001) (7)
Discoordinate regulation of contractile protein gene expression in the senescent rat myocardium. (1994) (7)
Slowly exchanging calcium binding sites unique to cardiac/slow muscle troponin C. (1990) (7)
The enduring relationship between myosin enzymatic activity and the speed of muscle contraction (2019) (7)
Heart failure and the response of cardiac myofilaments to Ca2 (1994) (6)
Analysis of the editorial review process of the Journal of Molecular and Cellular Cardiology. (2018) (6)
Suppression of cardiomyocyte functions by β-CTX isolated from the Thai king cobra (Ophiophagus hannah) venom via an alternative method (2020) (6)
Cardiac sarcomeric function, small G-protein signaling, and heart failure. (2005) (6)
Mechanics of cardiac contraction and the phosphorylation of sarcotubular and myofilament proteins (1987) (5)
Calcium Sensitizers and Molecular Mechanisms of Altered Response of Cardiac Myofilaments to Calcium (1996) (5)
A Perspective on Personalized Therapies in Hypertrophic Cardiomyopathy. (2020) (5)
Reversal of effects of acidosis on contraction of rat heart myocytes by CGP-48506. (2008) (5)
Editorial: Ca2+ Signaling and Heart Rhythm (2016) (4)
Troponin I in the murine myocardium: influence on length‐dependent activation and interfilament spacing (2003) (4)
B-arrestin-2 Signaling Is Important to Preserve Cardiac Function During Aging (2021) (4)
Cardiac Proteomics (2014) (4)
Impact of anesthesia and storage on posttranslational modifications of cardiac myofilament proteins (2015) (4)
Cardiac Troponin T Isoforms Affect the Ca2+ Sensitivity of Force Development in the Presence of Slow Skeletal Troponin I (2004) (3)
Biophysics of the failing heart (2013) (3)
Deletion of P21-activated kinase-1 induces age-dependent increased visceral adiposity and cardiac dysfunction in female mice (2021) (3)
Role of the C-terminus mobile domain of cardiac troponin I in the regulation of thin filament activation in skinned papillary muscle strips. (2018) (3)
Myofilament calcium sensitization delays decompensated hypertrophy differently between the sexes following myocardial infarction. (2011) (3)
Structure of the C-domain of Human Cardiac Troponin C in Complex with Ca2+ Sensitizer EMD 57033 (2001) (3)
Pak1: steps towards understanding the regulatory mechanisms of pacemaker function of the heart. (2007) (3)
Why we need to understand the mechanics of developing cardiac sarcomeres in humans (2016) (3)
Reversal of phosphate induced decreases in force by the benzimidazole pyridazinone, UD-CG 212 CL, in myofilaments from human ventricle (1997) (2)
Thematic Minireview Series on Signaling in Cardiac Sarcomeres in Health and Disease* (2011) (2)
Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in troponin T, via reduced expression of phospholamban (2018) (2)
Abstract 19199: Cardiomyocyte Enriched MicroRNA, Mir-378, Regulates Hypertrophy Agonists Stimulated Growth of Cardiac Myocytes (2012) (2)
Regulation of Cardiac Contraction p 21-Activated kinase-1 and its role in integrated regulation of cardiac contractility (2007) (2)
Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca2+-Activation of Mature and Immature Mouse Cardiac Myofilaments (2022) (2)
An internal domain of -tropomyosin increases myofilament Ca sensitivity (2009) (2)
Control of cardiac function in health and disease by mechanisms at the level of the sarcomere (2005) (2)
A sarcomeric protein tongue-twister: post-translation, citrullination/deimination and elimination of arginine residues. (2015) (2)
NH2-Terminal Cleavage of Cardiac Troponin I Signals Adaptive Response to Cardiac Stressors (2021) (2)
Mechanisms of troponin release into serum in cardiac injury associated with COVID-19 patients (2021) (2)
A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis from Pressure Overload by Targeting NFAT Signaling and Periostin (2013) (2)
E-1020, a water soluble imidazopyridine, has direct effects on Ca2+-dependent force and ATP hydrolysis of canine and bovine cardiac myofilaments (1996) (2)
The effect of Mg2+ on Ca2+ binding to cardiac troponin C in hypertrophic cardiomyopathy associated TNNC1 variants (2022) (2)
Abstract 1389: PKA Constitutes a Novel Activator of Cardiac Protective Pak1 Signaling (2008) (2)
The Hippo Signaling Pathway as a Drug Target in Familial Dilated Cardiomyopathy (2022) (1)
Rescue of a Dilated Cardiomyopathy Mouse Model Caused by a Mutation in Tropomyosin (E54K) by Expression of Slow Skeletal Troponin I (2012) (1)
REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN THE CALCIUM-SATURATED STATE, NMR, 40 STRUCTURES (1998) (1)
Erratum: Solution structures of the C-terminal domain of cardiac troponin C free and bound to the N-terminal domain of cardiac troponin I (Biochemistry (June 29, 1999) 38:26 (8313-8322)) (1999) (1)
Translational medicine with a capital T, troponin T, that is. (2007) (1)
Advances in understanding the state of titin truncation variants in dilated cardiomyopathy (2022) (1)
Kate Bárány: a life of science, teaching, and service (2012) (1)
Tropomyosin Pseudo-Phosphorylation and Muscle Kinetics (2010) (1)
Left Ventricular Diastolic and Systolic Pressure, Ejection, and Relaxation Reflect Sarcomeric Mechanical Properties (2011) (1)
Abstract 754: Expression Analysis and Functional Significance of a Novel Cardiac Specific Human Tropomyosin in Normal and Cardiomyopathy Patients (2007) (1)
Biophysics of the Failing Heart Physics and Biology of Heart Muscle (2013) (1)
Ca2+ Signaling and Heart Rhythm (2016) (1)
Cardiomyopathy Ctnt Mutation in Patient Derived Cardiomyocytes from Induced Pluripotent Stem Cells Affects Sarcomere Structure and Function (2014) (1)
When hearts fail so does skeletal muscle: breaking a vicious cycle. (2006) (1)
Heart Failure as a Failure of Contractility (2011) (1)
Thin Filament Regulation and Cardiac Energetics (1995) (1)
Physiology of the Myocardium (2010) (1)
Effects of sarcomere length on the force-pCa relation and troponin C calcium binding of chemically skinned fibers of canine ventricular muscle (1985) (1)
Toward an understanding of the regulation of myofibrillar function (2018) (1)
A perspective on Notch signalling in progression and arrhythmogenesis in familial hypertrophic and dilated cardiomyopathies (2023) (1)
Abstract 957: A Novel Interaction of Cardiac Troponin T with PKA Regulatory Subunits I and II (2007) (1)
Troponin I Ser-150 pseudo-phosphorylation alters cardiac contractile mechanics (2009) (0)
Myofibrillar Ca++ activation and heart failure — Ca++ sensitization by the cardiotonic agent APP 201-533 (1989) (0)
Association of Chairmen of Departments of Physiology 1995 survey results. (1996) (0)
Functional studies in human cardiac tissue obtained from endomyocardial biopsies (1998) (0)
Role of Sarcomeres in Cellular Tension, Shortening, and Signaling in Cardiac Muscle (2012) (0)
Altered Flexibility affects Regulatory Functions of Cardiac α-Tropomyosin (α-Tm) in a Novel Transgenic Mouse Model Expressing α-Tm-D137L (2013) (0)
Introduction to the Biophysics of the Failing Heart (2013) (0)
Negative inotropic mechanisms of β-cardiotoxin in cardiomyocytes by depression of myofilament ATPase activity without activation of the classical β-adrenergic pathway (2021) (0)
Control of Contractility Is at the Cellular Level of Organization (2011) (0)
Abstract 13392: Deficiency of Microrna-378 Contributes to the Development of Cardiac Fibrosis Involving a Tgfβ1-dependent Paracrine Mechanism (2014) (0)
Arrhythmogenesis, Heart Failure, and the Biophysics of Z-Band Protein Networks (2013) (0)
Abstract 460: Sex-Related Changes in Physiological Cardiac Hypertrophy in Beta Arrestin-2 KO mice (2019) (0)
Reply to Smith letter: Controversy persists after over 100 years of the Frank–Starling mechanism (2010) (0)
An Internal Domain of Beta Tropomyosin Increases Myofilament Calcium Sensitivity (2009) (0)
Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic cardiomyopathy (2023) (0)
A mouse model for α-tropomyosin mutation that causes familial hypertrophic cardiomyopathy (2001) (0)
P21 activated kinase-1 deficiency in cardiomyocytes increases in susceptibility to ventricular arrhythmogenesis in mice (2012) (0)
Inhibition of Angiotensin II-Induced Ventricular Hypertrophy and Fibrosis by Modulation of Pak1 Activity (2012) (0)
A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. (2017) (0)
Sub-Proteomic Fractionation of Rat Cardiac Tissue: Comparing Ischemic Vs Normal Remote Region with In-Solution Based Proteomics (2010) (0)
Regulation of L-type Calcium Channel Activity by P21 activated kinase-1 in Guinea-pig Sino-atrial Node Pacemaker Cells (2006) (0)
IL-6 Integrated biology and molecular mechanisms of cardiac myofilament activation (2002) (0)
Tropomyosin-Kappa Alters Cardiac Dynamics in a Mouse Heart Model (2010) (0)
Slowly exchanging ca-binding sites unique to the cardiac/slow muscle variant of troponin C (1987) (0)
The Effect of EMD 57033 is Decreased in Myofilaments from Transgenic Mouse Hearts over-expressing Slow Skeletal Troponin I (ssTnI) • 81 (1998) (0)
Abstract 416: Sarcomere Disassembly After Unloading is Regulated by Ubiquitination and Acetylation of Capz and α-actinin (2020) (0)
Introduction: Contractility and the Integrative Biology of the Myocardium (2011) (0)
in Perinatal and Adult Rat Hearts (2005) (0)
STRUCTURE of N-TERMINAL DOMAIN of CARDIAC TROPONIN i COMPLEXED with CARDIAC TROPONIN C (1998) (0)
Abstract 13486: MicroRNA-378 Targets IGF1 Receptor and Regulates Cardiomyocyte Survival (2011) (0)
Effect of cross bridge connections on cation selectivity of myofibrillar troponin C (1978) (0)
Erk1-Mediated Development of Left Ventricular Cardiac Hypertrophy in a P21 Activated Kinase-1 (Pak1) Knockout Mouse Model (2011) (0)
SIGNALING IN SARCOMERES AND CARDIAC ARRYTHYMIAS (2009) (0)
Novel Roles of Cardiac Sarcomeric Proteins in Signaling and Signal Transduction (2006) (0)
Cellular basis for post-cardioplegic cardiac dysfunction (1997) (0)
Regulation of cardiac sarcoplasmic reticulum in vitro and in vivo (1980) (0)
Integration of Sarcomere Mechanics with Cardiac Function Clarifies the Meaning of Preload, Afterload, and Contractility (2011) (0)
Truncation of the Mobile Domain of Cardiac Troponin I Results in Biphasic Calcium-Dependent Thin Filament Activation (2014) (0)
Development of left ventricular cardiac hypertrophy in a p21-activated kinase 1 knockout mouse model is mediated by Erk1 and PP2A. (2011) (0)
P21-Activated Kinase (Pak1) is a Direct Modulator of Cardiac Excitation-Contraction Coupling (ECC) Gain (2012) (0)
by workfollows function: how muscle shape is regulated (2015) (0)
CORONARY INSUFFICIENCY UNDERLIES FIBROTIC HCM PROGRESSION (2020) (0)
Abstract 8840: P21-Activated Kinase Improves Myocardial Performance through Modulation of Troponin-T and Myosin Light Chain 2 during Global Myocardial Ischemia and Reperfusion Injury (2011) (0)
Editorial Board (1991) (0)
MKK4 and Pak1 signalling in the heart, intriguing candidate targets for upstream therapy of cardiac arrhythmias (2012) (0)
Abstract 1238: Myofilament Calcium Sensitization Creates Arrhythmia Susceptibility in Familial Hypertrophic Cardiomyopathy (2007) (0)
ST-H-1 Molecular mechanisms and therapeutics of myofilament Ca2+ — Sensitization (2002) (0)
mechanisms via PIP2- and PKC-dependent CapZ dynamics are altered by endothelin-1 and (2009) (0)
pressure-volume relationships ventricular integrating cardiac muscle contraction into Dynamic left ventricular elastance: a model for (2015) (0)
Comprar Biophysics of the Failing Heart | R. Solaro | 9781461476771 | Springer (2013) (0)
as part of a mechanism protecting cardiomyocytes against ischemic cell injury 2 (2011) (0)
P21-Activated Kinase-1 and Fty720 Alter Atrial Excitation-Contraction Coupling (2011) (0)
Vanadate and phosphate alter cross-bridge kinetics in skinned cardiac muscle (1980) (0)
Monitoring Cardiac Troponin Structural Changes using In-Situ Time-Resolved FRET: Implications on the Regulatory Roles of Cross-Bridges and Sarcomere Length (2014) (0)
CALL FOR PAPERS Sex Differences in Renal and Cardiovascular Function: Physiology and Pathophysiology Myofilament response to Ca 2 and Na/H exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis (2007) (0)
Sarcomere Lengthdependent Effects on the Ca2+-Troponin Regulation in Skinned Myocardial Fiber from Titin RBM20 Deletion Mice (2017) (0)
Special Report Research Priorities in Hypertrophic Cardiomyopathy Report of a Working Group of the National Heart, Lung, and Blood Institute Genetic Cause (2010) (0)
Truncation of the N-terminus of cardiac troponin I initiates adaptive remodeling of the myocardial proteosome via phosphorylation of mechano-sensitive signaling pathways (2022) (0)
Abstract 11185: Expression of Slow Skeletal TnI Confers Metabolic Protection to Ischemia via Increased Glycolysis (2010) (0)
Increased Risk of Atrial Fibrillation with Attenuated Activity of P21-Activated Kinase (2014) (0)
Excitation-contraction uncoupling by diacetyl monoximes in cardiac muscle (1984) (0)
Heart failure and molecular signaling in cardiac myofilaments (1998) (0)
Abstract 20407: Restoration of p21-Activated Kinase (Pak1) Activity Attenuates Arrhythmic Activity in a Dog Model of Atrial Fibrillation (2014) (0)
Abstract 312: Selective Inhibition of Myocardial NADPH Oxidase Significantly Decreases Heart Size in Transgenic (Tg) Mice with Cardiac-Specific Overexpression of a Dominant-Negative (DN) Mutant of p67phox (2008) (0)
EDITORIAL COMMENT Genetics of Dilated Cardiomyopathy (2004) (0)
Altered Myofilament Targeting with Differential PKCδ Activation (2009) (0)
Abstract 621: Cardiac Myosin Binding Protein-C Phosphorylation in Ser-273 and Ser-282 is Critical to Maintain Cardiac Function During Aging (2019) (0)
Abstract 3573: Protection of Hypothermia-induced Contractile Dysfunction in Mice With Cardiac Specific Expression of Slow Skeletal Troponin I (2009) (0)
P21-Activated Kinase (Pak1) is a Negative Regulator of ROS Generation in Ventricular Myocytes (2013) (0)
Functional significance of differences in isoform population of thin filament proteins in developing heart (1991) (0)
P115Pak1 is required to maintain ventricular Ca2+ homeostasis and electrophysiological stability through SERCA2a regulation in mice. (2014) (0)
Abstract P1058: Whole-cell Mechanical Loading And Unloading Triggers More Post-translational Modifications In α-actinin Than Myosin Activators And Inhibitors (2022) (0)
Pressure Volume Loops Provide a Quantification of Contractility (2011) (0)
In-Solution Proteomic Workflow for Purification of Endogenous Sarcomeric Proteins and Identification of Distinct Charged Variants of Regulatory Light Chain (2009) (0)
Abstract 440: Improved Recovery of Reperfused Mouse Hearts Expressing Slow Skeletal Muscle TnI is Related to Reduced ATP Loss During Ischemia (2006) (0)
Modulation of the response of cardiac myofilaments to Ca2 (1992) (0)
Alterations to Cardiac Muscle Function and Sarcomeric Proteins Following Myocardial Infarction (2010) (0)
Dcm Mutations in Tropomyosin Induce Loss of Thermal Stability When the Mutation is Present in a Single Chain of the Tm Dimer (2014) (0)
PHOSPHORYLATED CARDIAC MYOSIN BINDING PROTEIN-C ENHANCES LUSITROPY (2014) (0)
Diseases of Cardiac Sarcomeres (2017) (0)
The Sphingosine‐1‐Phosphate Analog, FTY720, Reverses Diastolic Dysfunction and Hypertrophy in Familial Hypertrophic Cardiomyopathy (2017) (0)
Human Cardiac Troponin Cross-Linking and the Functional Consequences (2009) (0)
Pharmacotherapy of congestive heart failure (1989) (0)
Paracrine regulation of cardiac fibrosis by miR-378 1 Deficiency of cardiomyocyte-specific-microRNA-378 contributes to the development of cardiac fibrosis involving a TGFβ 1-dependent paracrine mechanism (2014) (0)
Abstract 1466: Re-expression of Slow Skeletal Troponin I Prevents Hypertrophic Remodeling during Ischemic Heart Failure (2007) (0)
Reactive Oxygen Species Alter Activation Of Cardiac Myofilaments And Modify Sarcomeric Proteins (2009) (0)
Troponin I in Skinned Rat Cardiac Muscle after Exchange of C-terminal Truncated Increased Cross-bridge Cycling Kinetics Mechanisms of Signal Transduction : (2008) (0)
Different studies report different findings about the roles of calcium in myocyte function and in the development of dilated cardiomyopathy. But determining whether increasing intracellular calcium is helpful or harmful for heart failure patients will require further investigation. (1999) (0)
Regulation of Ca(2+)-signaling in cardiac myofilaments. (1991) (0)
067The Sphingosine-1-Phosphate Receptor Modulator, FTY720, Reverses Diastolic Dysfunction and Hypertrophy in Hypertrophic Cardiomyopathy (2017) (0)
Into the golden anniversary of the yellow journal. (2017) (0)
Erratum: Inhibition of angiotensin II-induced ventricular hypertrophy and fibrosis by modulation of Pak1 activity (Biophysical Journal (2012) (556a)) (2012) (0)
Tetrahydrobiopterin Improves Diastolic Heart Failure by Increasing Myofilament Calcium Sensitivity (2012) (0)
CARDIAC MYOSIN-BINDING PROTEIN C PHOSPHORYLATION ENHANCES CARDIAC RELAXATION (2013) (0)
Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation (2020) (0)
microRNA‐378 inhibition promotes angiotensin II induced cardiac hypertrophy and fibrosis: role of paracrine signaling from cardiomyocytes to cardiac fibroblasts (868.1) (2014) (0)
Identification and Functional Significance of Troponin (2005) (0)
Sarcomere Length Dependent Effects on Ca2+-Induced Troponin Regulation within Chemically Skinned Cardiac Muscle Fibers (2016) (0)
proteins during development of heart failure Exercise training normalizes altered calcium-handling (2015) (0)
NMR STRUCTURE OF THE C TERMINAL DOMAIN OF CARDIAC TROPONIN C BOUND TO THE N TERMINAL DOMAIN OF CARDIAC TROPONIN I. (2000) (0)
Abstract 15083: Substitution of Adult Cardiac Troponin I, cTnI, With the Fetal Isoform, ssTnI, in Adult Mice Augments Metabolic Remodeling and Reduces Both Decompensatory Hypertrophy and Contractile Dysfunction During Chronic Pressure Overload (2013) (0)
Pak1 deficiency in cardiomyocytes increases in susceptibility to ventricular arrhythmogenesis in mice (2013) (0)
Therapeutic potential of FTY-720 for treating cardiac hypertrophic remodeling (2013) (0)
Proteomics for insights into ventricular arrhythmias (2013) (0)
Beta-cardiotoxin, a novel compound from king cobra venom, suppresses cardiac function via non-beta-adrenergic pathway. (2020) (0)
Kate Bárány: a life of science, teaching, and service (2012) (0)
Erratum: A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice (Journal of Molecular and Cellular Cardiology (2001) 33 (1815-1828)) (2001) (0)
Myofilament Dysfunction in a Guinea-pig model of Diastolic Heart Failure (2009) (0)
Cardiac Function Curves Provide a Compact Graphical Representation of Regulation of CO and SV (2011) (0)
Mg2+ effects on cardiac myofibrillar activation (1975) (0)
Pr65A Phosphorylaion Regulates PP2A Complexation and Signaling (2014) (0)
Contractility May Be Altered by a Variety of Mechanisms Not Involving a Prominent Role for the Autonomic Nervous System (2011) (0)
Abstract 226: p21-activated kinase-1 (Pak1) Mediates Exercise-induced Cardiac Remodeling Through Calcineurin Signaling (2015) (0)
Abstract 11855: Disruption of β-arrestin-2 Signaling Resulted in Impaired Systolic and Diastolic Function During Aging (2021) (0)
Introduction (1995) (0)
Cardiac-Specific Overexpression of a Dominant Negative (DN) p67phox Mutant Shows Reduction in Mouse Heart Size (2008) (0)
Solution structure of the bisphosphorylated cardiac specific N-extension of cardiac troponin I (2007) (0)
Myocardial Injury, Inflammation and Prothrombotic Response Are Associated with Outcomes of COVID-19 Patients (2021) (0)
Functional effects of P21-activated kinase-1 in guinea-pig sino-atrial (SA) node (2005) (0)
Deletion of P21-activated kinase-1 induces age-dependent increased visceral adiposity and cardiac dysfunction in female mice (2021) (0)
Figure 8, [Plot of the relation between...]. (2011) (0)
Abstract 40: Genetic Deletion Of Mir-208a Induces Pathological Remodeling And Heart Failure (2014) (0)
Three-dimensional spatial quantitative analysis of cardiac lymphatics in the mouse heart (2023) (0)
Myofilament calcium sensitization creates arrhythmia susceptibility in familial hypertrophic cardiomyopathy (2007) (0)
Maladaptive modifications in myofilament proteins and triggers in the progression to heart failure and sudden death (2014) (0)
DELETION OF P21-ACTIVATED KINASE-1 WORSENS AGE RELATED CARDIAC DYSFUNCTION IN FEMALES (2020) (0)
Myosin light chain phosphorylation hastens relaxation of skinned skeletal muscle fibers (1985) (0)
Abstract 20312: Rescue of a Mouse Model of Dilated Cardiomyopathy by Myofilament Sensitization to Calcium (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ross John Solaro?

Ross John Solaro is affiliated with the following schools:

Ross John Solaro's Academic­Influence.com Rankings

Ross John Solaro's Degrees

Why Is Ross John Solaro Influential?

Ross John Solaro's Published Works

Published Works

What Schools Are Affiliated With Ross John Solaro?

Ross John Solaro's AcademicInfluence.com Rankings